MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
Recently, MedCity News spoke with a pair of top executives at global supercomputing ...
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Strengthening Partnerships, Expanding Opportunity
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
After a relatively slow 2016 for life sciences deals...
We live in a golden age of medicine. Never before have so many effective treatment options been available to so many people. And precision medicine is bringing new horizons, as well as the promise to further improve disease prevention, treatment, and ultimately find more cures. To keep moving toward personalized medicine approaches, more individuals would […]
This independent editorial series on healthcare and the law is sponsored by Lake Whillans, a distressed venture capital and litigation finance firm that helps companies facing litigation or arbitration. As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift […]
Much like the calls for more data visualization in health IT at June’s Health Datapalooza, data visualizations can play a powerful role in improving the speed and quality of clinical trials. For example, the VP of ClinOps at a 20-year-old biotech start-up recently leveraged visualizations to help proactively manage a major last-minute patient enrollment challenge. […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.